[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CL2021001243A1 - Compuestos derivados de biciclo[2.2.1]heptano-2-carboxamida y tiofeno-2-carboxamida útiles para abrir canales de potasio kv7.4; composiciones farmacéuticas; y uso en el tratamiento de pérdida auditiva del oído interno después del daño o pérdida de células ciliadas sensoriales en un órgano de corti (divisional de la solicitud no. 201902445) - Google Patents

Compuestos derivados de biciclo[2.2.1]heptano-2-carboxamida y tiofeno-2-carboxamida útiles para abrir canales de potasio kv7.4; composiciones farmacéuticas; y uso en el tratamiento de pérdida auditiva del oído interno después del daño o pérdida de células ciliadas sensoriales en un órgano de corti (divisional de la solicitud no. 201902445)

Info

Publication number
CL2021001243A1
CL2021001243A1 CL2021001243A CL2021001243A CL2021001243A1 CL 2021001243 A1 CL2021001243 A1 CL 2021001243A1 CL 2021001243 A CL2021001243 A CL 2021001243A CL 2021001243 A CL2021001243 A CL 2021001243A CL 2021001243 A1 CL2021001243 A1 CL 2021001243A1
Authority
CL
Chile
Prior art keywords
carboxamide
loss
bicyclo
thiophene
heptane
Prior art date
Application number
CL2021001243A
Other languages
English (en)
Inventor
Michael Bös
Original Assignee
Acousia Therapeutics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acousia Therapeutics Gmbh filed Critical Acousia Therapeutics Gmbh
Publication of CL2021001243A1 publication Critical patent/CL2021001243A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/78Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/26Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/40Y being a hydrogen or a carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/43Y being a hetero atom
    • C07C323/44X or Y being nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/62Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C07C323/63Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/28Halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Fertilizers (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

En la presente solicitud se divulga compuestos derivados de biciclo[2.2.1]heptano-2-carboxamida y tiofeno-2-carboxamida útiles para abrir canales de potasio Kv7.4, sus composiciones farmacéuticas y su uso para preparar un medicamento útil en el tratamiento de pérdida auditiva del oído interno después del daño o pérdida de células ciliadas sensoriales en un órgano de Corti.
CL2021001243A 2017-02-28 2021-05-12 Compuestos derivados de biciclo[2.2.1]heptano-2-carboxamida y tiofeno-2-carboxamida útiles para abrir canales de potasio kv7.4; composiciones farmacéuticas; y uso en el tratamiento de pérdida auditiva del oído interno después del daño o pérdida de células ciliadas sensoriales en un órgano de corti (divisional de la solicitud no. 201902445) CL2021001243A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP17158326.3A EP3366683A1 (en) 2017-02-28 2017-02-28 Cyclic amides, acteamides and ureas useful as potassium channel openers

Publications (1)

Publication Number Publication Date
CL2021001243A1 true CL2021001243A1 (es) 2021-10-22

Family

ID=58192162

Family Applications (2)

Application Number Title Priority Date Filing Date
CL2019002445A CL2019002445A1 (es) 2017-02-28 2019-08-26 Nuevos compuestos útiles como abridores de canal de potasio.
CL2021001243A CL2021001243A1 (es) 2017-02-28 2021-05-12 Compuestos derivados de biciclo[2.2.1]heptano-2-carboxamida y tiofeno-2-carboxamida útiles para abrir canales de potasio kv7.4; composiciones farmacéuticas; y uso en el tratamiento de pérdida auditiva del oído interno después del daño o pérdida de células ciliadas sensoriales en un órgano de corti (divisional de la solicitud no. 201902445)

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CL2019002445A CL2019002445A1 (es) 2017-02-28 2019-08-26 Nuevos compuestos útiles como abridores de canal de potasio.

Country Status (24)

Country Link
US (2) US11034665B2 (es)
EP (3) EP3366683A1 (es)
JP (3) JP6795713B2 (es)
KR (2) KR102443685B1 (es)
CN (2) CN114105942B (es)
AU (2) AU2018227005B2 (es)
BR (2) BR112019017184B1 (es)
CA (2) CA3238405A1 (es)
CL (2) CL2019002445A1 (es)
CY (2) CY1123114T1 (es)
DK (2) DK3484863T3 (es)
ES (2) ES2813064T3 (es)
HR (2) HRP20201159T1 (es)
HU (2) HUE052703T2 (es)
IL (1) IL268931B (es)
LT (2) LT3484863T (es)
MX (2) MX2019010169A (es)
PH (1) PH12019550146A1 (es)
PL (2) PL3484863T3 (es)
PT (2) PT3484863T (es)
RS (2) RS60648B1 (es)
SI (2) SI3484863T1 (es)
WO (1) WO2018158256A2 (es)
ZA (1) ZA201905198B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3366683A1 (en) * 2017-02-28 2018-08-29 Acousia Therapeutics GmbH Cyclic amides, acteamides and ureas useful as potassium channel openers
US20230136562A1 (en) 2020-04-29 2023-05-04 Idorsia Pharmaceuticals Ltd Spirourea derivatives
KR20230029813A (ko) 2020-06-25 2023-03-03 이도르시아 파마슈티컬스 리미티드 시클로부틸-우레아 유도체
US20240009149A1 (en) * 2020-11-19 2024-01-11 Acousia Therapeutics Gmbh Non-aqueous gel composition
EP4279061A1 (en) * 2022-05-18 2023-11-22 Acousia Therapeutics GmbH Aqueous gel composition

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0594034A (ja) 1990-06-29 1993-04-16 Xerox Corp クラツクのない電子写真画像形成デバイス
EP0957099B1 (en) * 1998-04-15 2002-11-20 Pfizer Products Inc. Heterocyclic carboxamides
DE19929076A1 (de) 1999-06-25 2000-12-28 Aventis Pharma Gmbh Indanylsubstituierte Benzolcarbonamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
DE10061876A1 (de) * 2000-12-12 2002-06-20 Aventis Pharma Gmbh Arylierte Furan- und Thiophencarbonsäureamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
AR033095A1 (es) 2001-04-04 2003-12-03 Wyeth Corp Metodos para el tratamiento de motilidad gastrica hiperactiva
US7273866B2 (en) * 2002-12-20 2007-09-25 Bristol-Myers Squibb Company 2-aryl thiazole derivatives as KCNQ modulators
AU2004222626B2 (en) 2003-03-21 2010-06-24 H. Lundbeck A/S Substituted p-diaminobenzene derivatives
TWI349666B (en) 2004-03-12 2011-10-01 Lundbeck & Co As H Substituted morpholine and thiomorpholine derivatives
UA89503C2 (uk) 2004-09-13 2010-02-10 Х. Луннбек А/С Заміщені похідні аніліну
US20060188445A1 (en) 2005-02-22 2006-08-24 Fred Hutchinson Cancer Research Center Assay for compounds that protect against sensory hair cell death and compounds identified by same
US7790770B2 (en) * 2005-11-23 2010-09-07 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
WO2007087424A2 (en) 2006-01-25 2007-08-02 The Johns Hopkins University Method of treating kcnq related disorders using organozinc compounds
WO2007138112A2 (en) * 2006-06-01 2007-12-06 Devgen N.V. Compounds that interact with ion channels, in particular with ion channels from the kv family
US20090118274A1 (en) * 2007-02-15 2009-05-07 Darin Allen Monocyclic aminopropyl tetrahydro-pyrazolo-pyridine modulators of cathepsin s
DE102007032436B4 (de) 2007-07-10 2009-07-16 Heraeus Electro-Nite International N.V. Vorrichtung zum Sammeln von Gasen in Metallschmelzen
EP2185149A1 (en) * 2007-08-01 2010-05-19 H. Lundbeck A/S Use of kncq potassium channel openers for reducing symptoms of or treating disorders or conditions wherein the dopaminergic system is disrupted
BRPI0818581A2 (pt) 2007-10-17 2015-07-21 Sanofi Aventis Carboxamidas n-fenil-bipirrolidina substituídas e uso terapêutico das mesmas
EP2231602A1 (en) * 2007-12-13 2010-09-29 Amgen, Inc Gamma secretase modulators
US7786171B2 (en) * 2008-04-04 2010-08-31 Abbott Laboratories Amide derivatives as positive allosteric modulators and methods of use thereof
TW201038572A (en) 2009-03-25 2010-11-01 Gruenenthal Gmbh Substituted spiro-amide compounds
EP2438037A1 (en) * 2009-06-04 2012-04-11 Merz Pharma GmbH & Co. KGaA Glycine b antagonists
WO2011085351A2 (en) * 2010-01-11 2011-07-14 The Johns Hopkins University Method of treating kcnq related disorders
DE102010007281A1 (de) * 2010-02-08 2011-08-11 EMC microcollections GmbH, 72070 Neue Aminoalkyl-oxazol- und Aminoalkyl-thiazolcarbonsäureamide und ihre Anwendung zur Stimulation der endogenen situ Regeneration von Haarsinneszellen im Corti'schen Organ des Innenohres beim Säuger
US8586604B2 (en) * 2010-08-20 2013-11-19 Boehringer Ingelheim International Gmbh Inhibitors of the microsomal prostaglandin E2 synthase-1
TW201217312A (en) * 2010-09-22 2012-05-01 Gruenenthal Gmbh Substituted benzamide compounds
ES2656972T3 (es) * 2012-02-23 2018-03-01 Vanderbilt University Análogos de 5-aminotieno [2,3-c] piridazin-6-carboxamida como moduladores alostéricos positivos del receptor de acetilcolina muscarínico M4
CA2885828C (en) 2012-09-28 2021-04-27 University Of Washington Through Its Center For Commercialization Ureido-thiophenyl derivatives, compositions thereof and methods for preventing, treating and/or protecting against sensory hair cell death
WO2014079850A1 (en) * 2012-11-23 2014-05-30 F. Hoffmann-La Roche Ag Substituted heterocyclic derivatives
US9572815B2 (en) * 2013-03-15 2017-02-21 St. Jude Children's Research Hospital Methods and compositions of p27KIP1 transcriptional modulators
PL404138A1 (pl) * 2013-05-31 2014-12-08 Warszawski Uniwersytet Medyczny Pochodne kwasu benzoesowego jako inhibitory receptora IL-15Rα
US20150126507A1 (en) * 2013-09-05 2015-05-07 Fate Therapeutics, Inc. Compounds to treat hearing loss
CA2929194A1 (en) * 2013-11-05 2015-05-14 F. Hoffmann-La Roche Ag 5,6,7,8-tetrahydro-5,8-methanocinnoline derivatives as rorc modulators for the treatment of autoimmune diseases
ES2607752T3 (es) * 2013-11-12 2017-04-03 Acousia Therapeutics Gmbh Compuestos nuevos para regeneración de células y tejidos terminalmente diferenciados
CN105017085B (zh) 2014-04-28 2018-06-29 中国科学院上海药物研究所 一类kcnq钾通道激动剂、其制备方法和用途
US9493482B2 (en) * 2015-02-06 2016-11-15 University Of Washington Compounds and methods for preventing or treating sensory hair cell death
GB201601301D0 (en) * 2016-01-25 2016-03-09 Takeda Pharmaceutical Novel compounds
EP3366683A1 (en) * 2017-02-28 2018-08-29 Acousia Therapeutics GmbH Cyclic amides, acteamides and ureas useful as potassium channel openers

Also Published As

Publication number Publication date
MX2019010169A (es) 2019-10-21
PH12019550146A1 (en) 2020-06-08
EP3484863A2 (en) 2019-05-22
JP7474289B2 (ja) 2024-04-24
CN110312710A (zh) 2019-10-08
RU2019127116A (ru) 2021-03-30
BR112019017184B1 (pt) 2021-06-01
JP2021008479A (ja) 2021-01-28
KR102382795B1 (ko) 2022-04-05
RS61254B1 (sr) 2021-01-29
KR102443685B1 (ko) 2022-09-15
US20200157072A1 (en) 2020-05-21
JP2020510694A (ja) 2020-04-09
DK3484863T3 (da) 2020-09-07
PL3484863T3 (pl) 2020-12-14
CN110312710B (zh) 2022-02-15
HUE051854T2 (hu) 2021-03-29
JP6795713B2 (ja) 2020-12-02
BR122020025103B1 (pt) 2021-06-01
WO2018158256A2 (en) 2018-09-07
CL2019002445A1 (es) 2020-03-13
RU2019127116A3 (es) 2021-03-31
AU2018227005A1 (en) 2019-08-22
CA3052359A1 (en) 2018-09-07
MX2020010866A (es) 2022-02-28
BR112019017184A2 (pt) 2020-04-28
CN114105942A (zh) 2022-03-01
CY1123114T1 (el) 2021-10-29
ES2846772T3 (es) 2021-07-29
ZA201905198B (en) 2020-03-25
SI3567034T1 (sl) 2021-03-31
LT3567034T (lt) 2020-12-10
PT3484863T (pt) 2020-08-27
PT3567034T (pt) 2020-12-04
WO2018158256A3 (en) 2018-12-13
EP3567034B1 (en) 2020-10-28
EP3567034A1 (en) 2019-11-13
IL268931A (en) 2019-10-31
AU2021254653B2 (en) 2022-12-08
HRP20201159T1 (hr) 2020-11-13
AU2018227005B2 (en) 2021-11-11
PL3567034T3 (pl) 2021-05-17
KR20190105058A (ko) 2019-09-11
DK3567034T3 (da) 2021-01-11
CY1123488T1 (el) 2022-03-24
US20210261518A1 (en) 2021-08-26
KR20210134826A (ko) 2021-11-10
CA3238405A1 (en) 2018-09-07
JP2022166055A (ja) 2022-11-01
RS60648B1 (sr) 2020-09-30
ES2813064T3 (es) 2021-03-22
HRP20201961T1 (hr) 2021-02-05
AU2021254653A1 (en) 2021-11-18
EP3484863B1 (en) 2020-06-17
SI3484863T1 (sl) 2020-10-30
HUE052703T2 (hu) 2021-05-28
LT3484863T (lt) 2020-07-27
US11034665B2 (en) 2021-06-15
RU2020140167A (ru) 2020-12-16
CN114105942B (zh) 2024-07-12
IL268931B (en) 2021-10-31
RU2020140167A3 (es) 2021-04-23
EP3366683A1 (en) 2018-08-29
US11884642B2 (en) 2024-01-30

Similar Documents

Publication Publication Date Title
CL2021001243A1 (es) Compuestos derivados de biciclo[2.2.1]heptano-2-carboxamida y tiofeno-2-carboxamida útiles para abrir canales de potasio kv7.4; composiciones farmacéuticas; y uso en el tratamiento de pérdida auditiva del oído interno después del daño o pérdida de células ciliadas sensoriales en un órgano de corti (divisional de la solicitud no. 201902445)
PH12018550062A1 (en) Topical film-forming spray
CL2021000415A1 (es) Vesículas derivadas de lactobacillus paracasei y uso de las mismas
UA107653C2 (en) Extract of aerial parts of oats harvested before ear emergence
EA201692334A1 (ru) Кортикостероидные композиции для местного применения
EP3829569A4 (en) SPINOSYN FORMULATIONS FOR THE TREATMENT OF DEMODEX-INDUCED EYE AND FACIAL DISORDERS
EP4272832A3 (en) Antimicrobial compounds, compositions, and uses thereof
BR112017002879A2 (pt) balões revestidos e conjuntos de balões revestidos e métodos relacionados de uso e fabricação
MX2021012659A (es) Composiciones de seda para el cuidado del cabello.
WO2018183631A8 (en) Novel pharmaceutical formulations containing indirubin and derivatives thereof and methods of making and using the same
ECSP18060864A (es) Derivados de 3-(carboximetil)-8-amino-2-oxo-1,3-diaza-espiro-[4.5]- decano
CO2017003290A2 (es) Composiciones y kits para desbridación enzimática y metodos de uso de los mismos
PH12019500949A1 (en) Ror-gamma modulators
CO2020004407A2 (es) Formulaciones de espora de nutriente y usos de las mismas
BR112017005282A2 (pt) produtos para tratamento de pele
WO2016030841A3 (en) Novel care and/or makeup device comprising a composition of gel/gel architecture
GEP20237486B (en) Formulations of copanlisib
WO2020194087A3 (en) Extended release pharmaceutical formulation
CL2019003503A1 (es) Composiciones sinérgicas que comprenden dimiracetam (r) (1) y dimiracetam (s) (2) en una proporción no racémica.
MX2019011951A (es) Secretoma bacteriano para usarse en el tratamiento contra lesiones cutaneas.
PH12018501508A1 (en) Depilatory compositions
EA201991185A1 (ru) Композиции для личной гигиены, содержащие цистин
WO2017160694A3 (en) Compositions for providing vitamin d to the skin
CO2019014831A2 (es) Nuevas formulaciones orales de belinostat
EP3773932A4 (en) SKIN CARE COMPOSITIONS AND THEIR APPLICATIONS